Literature DB >> 17008621

Conjugate eye deviation in acute stroke: incidence, hemispheric asymmetry, and lesion pattern.

Oliver C Singer1, Marek C Humpich, Helmut Laufs, Heiner Lanfermann, Helmuth Steinmetz, Tobias Neumann-Haefelin.   

Abstract

BACKGROUND AND
PURPOSE: The authors studied clinical features and lesion patterns associated with conjugate eye deviation (CED) in acute stroke.
METHODS: Consecutive patients with supratentorial stroke (<6 hours after symptom onset) were prospectively recruited. CED was classified according to the National Institute of Health Stroke Scale (NIHSS) item "gaze palsy" as being forced, partial, or absent. Lesion patterns on diffusion-weighted images (DWI) were analyzed in 46 patients using a normalization procedure for direct comparisons between patients. Perfusion data were analyzed for a subset of patients.
RESULTS: Partial CED was found in 7 (6%) and forced CED in 31 (26.7%) of 116 patients. Forced and partial CED were associated with higher initial NIHSS scores compared with patients without CED (16 and 10 versus 5; P<0.05). DWI lesion volume was larger in patients with CED (103.24+/-102.4 mL, mean+/-SD) as compared with patients without CED (17+/-34.98 mL, P<0.001). CED was more frequent in right hemispheric stroke (44.6% versus 23%, P<0.02). DWI pattern analysis in patients with CED with right hemispheric stroke revealed a network of affected regions, including basal ganglia and temporoparietal cortex. In left hemispheric CED, lesions were larger than in patients without CED, but no consistent pattern could be established. In a subset of selected patients with CED, a small temporoparietal perfusion deficit was sufficient to elicit CED.
CONCLUSIONS: Selective dysfunction of cortical areas involved in spatial attention and control of eye movements is sufficient to cause CED in patients with acute stroke. However, in the majority of cases, CED is an indicator of large infarcts involving more than one area, including both cortical and subcortical structures.

Entities:  

Mesh:

Year:  2006        PMID: 17008621     DOI: 10.1161/01.STR.0000244809.67376.10

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

Review 1.  Imaging correlates of neural control of ocular movements.

Authors:  Mohit Agarwal; John L Ulmer; Tushar Chandra; Andrew P Klein; Leighton P Mark; Suyash Mohan
Journal:  Eur Radiol       Date:  2015-09-22       Impact factor: 5.315

2.  Conjugate Eye Deviation on CT Associated With Worse Outcomes Despite IV Thrombolysis.

Authors:  Nirav H Shah; Nirav Bhatt; Anita Tipirneni; Diego Condes; Priyank Khandelwal; Jose G Romano
Journal:  Neurohospitalist       Date:  2016-10-24

3.  Prognostic information of gaze deviation in acute ischemic stroke patients.

Authors:  Ana Lima Silva; Ana Sofia Pessoa; Renato Nogueira; José Manuel Araújo; José Nuno Alves; João Pinho; Carla Ferreira
Journal:  Neurol Sci       Date:  2019-11-11       Impact factor: 3.307

4.  Cortical symptoms described in emergency calls for patients with suspected large vessel occlusion: a descriptive analysis of 157 emergency calls.

Authors:  Pauli Vuorinen; Joonas Kiili; Essi Alanko; Heini Huhtala; Jyrki Ollikainen; Piritta Setälä; Sanna Hoppu
Journal:  BMC Emerg Med       Date:  2022-08-13

5.  Conveniently-Grasped Field Assessment Stroke Triage (CG-FAST): A Modified Scale to Detect Large Vessel Occlusion Stroke.

Authors:  Xiaoxian Gong; Zhicai Chen; Feina Shi; Meixia Zhang; Chao Xu; Ruiting Zhang; Min Lou
Journal:  Front Neurol       Date:  2019-04-17       Impact factor: 4.003

6.  Bringing prevost's sign into the third dimension: Artificial intelligence estimation of conjugate gaze adjusted length (CGAL) and correlation with acute ischemic stroke.

Authors:  Hillel S Maresky; Joseph M Rootman; Miriam M Klar; Max Levitt; Alexander P Kossar; David Zucker; Michael Glazier; Shani Kalmanovich-Avnery; Richard Aviv; Birgit Ertl-Wagner; Sigal Tal
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.